|
Sarcoma drug approvals in Latin America compared to the FDA and EMA: An analysis by the LACOG Sarcoma Group. |
|
Roberto Carmagnani Pestana |
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Merck; Pfizer; SERVIER |
Consulting or Advisory Role - Bayer; SERVIER |
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Knight Therapeutics; Merck; Pfizer; SERVIER |
Research Funding - SERVIER (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Deciphera |
Research Funding - Deciphera; PTC Therapeutics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Veridiana Pires De Camargo |
No Relationships to Disclose |
|
Celso Abdon Lopes de Mello |
Consulting or Advisory Role - BOEHRINGER INGELHEIM, SERVIER, and ADDIUM |
Speakers' Bureau - ERVIER and ADDIUM |
Travel, Accommodations, Expenses - Boehringer Ingelheim |
|
Lucila Maria González Donna |
Research Funding - ASCO-PFIZER GRANT |
|
|
Honoraria - BMS; Merck Serono; MSD; Novartis; Pfizer; Sanofi |
Consulting or Advisory Role - BMS; MSD; Sanofi |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Sanofi |
Research Funding - Bayer; Bristol-Myers Squibb; MSD; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
Juan Carlos Carlos Haro Varas |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Cicero Luiz Cunha De Sousa Martins |
Consulting or Advisory Role - MSD and ASTRAZENECA |
|
|
|
|
Reynaldo Jesus Garcia Filho |
No Relationships to Disclose |